Home : FDA Drug Database : Abacavir Sulfate : Newsfeeds

Abacavir Sulfate - Newsfeeds

Gilead Sciences And Merck & Co., Inc. Agree To Register And Distribute HIV Medication In Twelve Countries
Gilead Sciences, Inc. (Nasdaq:GILD) and Merck & Co., Inc. (NYSE:MRK) announced that the companies have entered into an agreement through which Gilead will assume the lead role for the distribution of Atripla® (efavirenz 600 mg/ emtricitabine 200 mg ...
Fast Track Approvals
N21854 stavudine 40mg; lamivudine 150mg tablets Co-Packaged with nevirapine 200mg tablets Strides Arcolab 3/13/2007 Treatment of HIV N21838 stavudine 40mg; lamivudine 150mg Fixed-Dose Combination Tablets Strides Arcolab 3/13/2007 Treatment of HIV N21988 ...
Accelerated and Restricted Approvals Under Subpart H (drugs) and Subpart E (biologics)
The Therapeutic Biologic Products transferred from CBER to CDER effective 1-Oct-03. R - Restricted - Approval with restrictions to assure safe use as recorded in 21 CFR 601.42 (Subpart E). S - Surrogate - Approval based on a surrogate endpoint or on an ...
Patent challenges reduce pharmaceutical innovation and productivity, researchers say
The development of new and innovative pharmaceuticals is being stifled by a U.S. law and successful patent challenges that embolden generic competition, according to an article published in this week's issue of the journal Science . Matthew Higgins and ...
Ziagen (abacavir)
Ziagen tablets and oral solution contain the active ingredient abacavir sulfate, which is a type of medicine called a nucleoside reverse transcriptase inhibitor (NRTI). It is used in the treatment of HIV (human immunodeficiency virus) infection.
Gilead Initiates Phase III Clinical Program Evaluating Single-Tablet, Once-Daily "Quad" Regimen For HIV
Due to similarities between Emtriva and lamivudine, Atripla should not be coadministered with drugs containing lamivudine, including Combivir® (lamivudine/zidovudine), Epivir® or Epivir-HBV® (lamivudine), Epzicom® (abacavir sulfate/lamivudine) or ...
Gilead Sciences Submits New Drug Application to U.S. FDA for Once-Daily Single-Tablet Regimen of Truvada ...
FOSTER CITY, Calif.--( BUSINESS WIRE )--Gilead Sciences, Inc. (Nasdaq:GILD) today announced that it has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for marketing approval of the single-tablet regimen of Truvada ...
Citigroup begins auction of Biofarma; Cephalon's Baldino won't be back in 2010 ;
> Citigroup's venture capital arm and two co-investors have begun an auction of Turkish copycat drugmaker Biofarma, three people familiar with the matter said, in what could be Turkey's biggest healthcare deal. Article > Cephalon (Nasdaq: CEPH) has ...
Shionogi-ViiV Healthcare Starts Phase III Trial for '572-Trii' Fixed-Dose Combination HIV Therapy
About KIVEXA/EPZICOM KIVEXA/EPZICOM (abacavir/lamivudine) is a once-a-day HIV medication that combines abacavir sulfate and lamivudine in a single tablet and is indicated for the treatment of HIV-1 infection in adults. Important Information about EPZICOM ...
Gilead's Single-Tablet “Quad” HIV Regimen Maintains High Viral Suppression ...
including Combivir ® (lamivudine/zidovudine), Epivir ® or Epivir-HBV ® (lamivudine), Epzicom ® (abacavir sulfate/lamivudine) or Trizivir ® (abacavir sulfate/lamivudine/zidovudine). In treatment-experienced ...
Do you need a Washington, DC Abacavir Sulfate attorney? Contact one of our Washington, DC Abacavir Sulfate attorneys now.

Content provided by MSN. LegalView is not responsible for the accuracy of the information provided above.

Need An Abacavir Sulfate Attorney?

First Name Last Name Email Address State
Has Your Health Been Negatively Affected?

Please Describe the Injury

Your Friend's Email Address

Your Email Address

Type a Message (optional)


Do you need a Washington, DC Abacavir Sulfate attorney? Contact one of our Washington, DC Abacavir Sulfate attorneys now.

 

Close (x)

Looking for an Attorney?


Please type your question:

Close (x)

logo Find Legal Help for Your Abacavir Sulfate Case - Submit Your Information Below

Do you need legal assistance with your Abacavir Sulfate case?
LegalView may be able to help.


Submit your information below for a free, no-cost evaluation.

We'll submit your information to one of our partner firms.
LegalView's partners represent clients throughout the United States, for a very wide range of legal issues. Submit your information now, to see if one of LegalView's partners can help!

* Indicates Required Fields

First name *
Last name *
Email Address *
Phone Number *
()  -

State *
Legal Issue * FDA Drug Database: Abacavir Sulfate Change
Was There an Injury?
Please Describe The Injury

DISCLAIMER and STATEMENT OF NON-CONFIDENTIALITY

By submitting this form, you agree that completing the above is not intended to create an attorney-client relationship.

Disclosure

Legal WebTV Network LLC, LegalView.com, and LegalWebMedia.com are group advertising sponsored by the attorneys identified here. It is not a lawyer referral service. If you submit information on this website [more...]

Legal WebTV Network LLC, LegalView.com, and LegalWebMedia.com are group advertising sponsored by the attorneys identified here. It is not a lawyer referral service. If you submit information on this website, LegalWebMedia.com will submit your information to the law firms that pay for this group advertising and to respond to your requests for information concerning legal services in their assigned local areas. If there is no sponsoring firm in your state, your inquiry will be submitted to one of the sponsoring law firms on a predetermined, rotating basis. If the sponsoring law firm accepts your case, it will associate with licensed attorneys practicing in your state, if required; the sponsoring law firm may also contact other law firms to see if they may be able to assist.

The information provided by the LegalView.com and LegalWebMedia.com websites is for advertising and informational purposes and should not be considered as legal advice from the sponsoring attorneys. The websites contain general information and may not reflect current legal developments, verdicts, or settlements. LegalView.com contains information created by others or supplied through open forums; the sponsoring law firms are not responsible for the accuracy of this information. Any person viewing or receiving information from these websites should not act or refrain from acting on the basis of any such information without first seeking appropriate legal advice from an attorney in your area. Legal WebTV Network, LLC expressly disclaims any liability with respect to actions taken or not taken by the recipient based on any or all of the information or contents contained in these websites.

Any information sent to Legal WebTV Network LLC through this website is done using standard Web encryption techology. LegalView.com will exercise all reasonable care, within technological limits, to protect the confidentiality of any information submitted via Internet e-mail or through this website. By accessing this website, you may be seeking an attorney to represent you or legal advice. However, none of the sponsoring attorneys represent you yet.

The choice of a lawyer is an important decision and should not be based solely upon advertisements.

Any transmission of information, whether via Internet e-mail or through the website, is solely for evaluation purposes by the sponsoring law firms and their associates. The transmission of any information to any attorney sponsoring advertising on LegalView.com or LegalWebMedia.com does not create an attorney-client relationship between the sender and any recipient. An attorney-client relationship can only be created by a written, signed-fee agreement entered into with an attorney. The sponsoring attorneys will treat your information as a confidential communication for the purpose of obtaining legal services or legal advice.

For more information about the sponsoring law firms, please click here.
This form is secure and encrypted. More information about secure forms and your privacy here.